Calcium Antagonist Protects the Myocardium from Reperfusion Injury by Interfering with Mechanisms Directly Related to Reperfusion: An Experimental Study with the Ultrashort-Acting Calcium Antagonist Clevidipine-Reference-Cited by-同舟云学术

Calcium Antagonist Protects the Myocardium from Reperfusion Injury by Interfering with Mechanisms Directly Related to Reperfusion: An Experimental Study with the Ultrashort-Acting Calcium Antagonist Clevidipine

Published:2000-09 Issue:3 Volume:36 Page:338-343
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Segawa Daisuke,Sjöquist Per-Ove,Wang Qing-Dong,Gonon Adrian,Nordlander Margareta,Rydén Lars

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference36 articles.

1. Diltiazem and progression of myocardial ischemic damage during coronary artery occlusion and reperfusion in porcine hearts

2. Protective Effects of Benidipine against Myocardial Damage Following Ischemia and Reperfusion in the Isolated Perfused Rat Heart.

3. Preischaemic as well as postischaemic application of a calcium antagonist affords cardioprotection in the isolated guinea pig heart

4. Calcium antagonists and the stunned myocardium: a role during ischaemia? A role during reperfusion?

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of caveolin-eNOS platform and mitochondrial ATP-sensitive potassium channel in abrogated cardioprotective effect of ischemic preconditioning in postmenopausal women;Brazilian Journal of Pharmaceutical Sciences;2022

2. Perioperative Hypertensive Crisis;International Anesthesiology Clinics;2012

3. Hypertensive emergencies;Current Opinion in Critical Care;2011-12

4. Clevidipine for severe hypertension in patients with renal dysfunction: A VELOCITY trial analysis;Blood Pressure;2010-11-23

5. Clevidipine: A Short-Acting Intravenous Dihydropyridine Calcium Channel Blocker for the Management of Hypertension;Pharmacotherapy;2010-05